Status:

COMPLETED

Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients

Lead Sponsor:

Vanderbilt University

Conditions:

End Stage Renal Disease

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The goal of this study is to evaluate the metabolic effects of concomitant use of three consecutive doses of recombinant human growth hormone over three days and exercise during continuous nutrient in...

Eligibility Criteria

Inclusion

  • On hemodialysis for more than 6 months, on a thrice weekly hemodialysis program;
  • Adequately dialyzed (Kt/V \> 1.4).

Exclusion

  • Patients unable to perform exercise.
  • Pregnant women.
  • Severe unstable underlying disease besides commonly associated with ESRD. Cardiac patients that are stable will be included.
  • Patients hospitalized within the last month prior to the study.
  • Patients with recirculation detected on the AV graft.
  • Patients receiving steroids and/or other immunosuppressive agents

Key Trial Info

Start Date :

July 1 1998

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2006

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT00244075

Start Date

July 1 1998

End Date

August 1 2006

Last Update

May 25 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University

Nashville, Tennessee, United States, 37232